NUVB

1.82

7.61% -0.15

Handel nachbörslich: 1.81 -0.01 -0.55%

Nuvation Bio Inc (NUVB)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$1.97

Offen:

$2.1

24-Stunden-Volumen:

5.76M

Relative Volume:

2.48

Marktkapitalisierung:

$681.55M

Einnahmen:

Nettoeinkommen (Verlust:

$-75.80M

KGV:

-5.20

EPS:

-0.35

Netto-Cashflow:

$-68.07M

1W Leistung:

-12.50%

1M Leistung:

-19.82%

6M Leistung:

-38.93%

1J Leistung:

-18.39%

1-Tages-Spanne:

$1.80

$2.19

1-Wochen-Bereich:

$1.80

$2.19

52-Wochen-Spanne:

$1.67

$4.1598

Nuvation Bio Inc Stock (NUVB) Company Profile

Firmenname

Nuvation Bio Inc

Sektor

Healthcare (1189)

Branche

Biotechnology (682)

Telefon

(415) 754-3517

Adresse

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Mitarbeiter

203

Twitter

Nächster Verdiensttermin

2025-03-03

Neueste SEC-Einreichungen

NUVB's Discussions on Twitter

Vergleichen Sie NUVB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NUVB Nuvation Bio Inc	1.82	681.55M	0	-75.80M	-68.07M	-0.35
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-27	Hochstufung	Jefferies	Hold → Buy
2024-03-26	Hochstufung	BTIG Research	Neutral → Buy
2023-01-06	Herabstufung	Jefferies	Buy → Hold
2022-08-02	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2022-08-02	Herabstufung	BTIG Research	Buy → Neutral
2022-05-04	Eingeleitet	H.C. Wainwright	Buy
2021-10-15	Fortgesetzt	BTIG Research	Buy
2021-04-06	Eingeleitet	RBC Capital Mkts	Outperform
2021-03-08	Eingeleitet	BMO Capital Markets	Outperform
2021-03-08	Eingeleitet	BTIG Research	Buy
2021-03-08	Eingeleitet	Cowen	Outperform
2021-03-08	Eingeleitet	Jefferies	Buy
2021-03-08	Eingeleitet	Wedbush	Outperform

Alle ansehen

Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten

04:34 AM

New York's Nuvation Bio Nets $250M to Launch Lung Cancer Game-Changer - Hoodline

04:34 AM

12:54 PM

Midtown biotech raises $250M to bring lung cancer therapy to market - Crain's New York Business

12:54 PM

10:51 AM

Nuvation Bio to Receive Up to $250 Million in Funding From Sagard Healthcare Partners - Marketscreener.com

10:51 AM

10:48 AM

RBC bullish on Nuvation as royalty deal, non-dilutive financings remove overhang - TipRanks

10:48 AM

10:03 AM

Nuvation Bio nabs $250 million to launch cancer drug - The Pharma Letter

10:03 AM

09:31 AM

Nuvation Bio Secures Up To $250 Million In Non-Dilutive Financings From Sagard Healthcare Partners - Marketscreener.com

09:31 AM

09:15 AM

Nuvation Bio secures $250 million for cancer drug launch - Investing.com

09:15 AM

08:59 AM

Nuvation Bio secures up to $250M from Sagard Healthcare Partners; shares rise - MSN

08:59 AM

08:35 AM

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners - Business Wire

08:35 AM

Feb 27, 2025

Nuvation Bio (NUVB) to Release Earnings on Thursday - Defense World

Feb 27, 2025

Analyzing Sage Therapeutics (NASDAQ:SAGE) and Nuvation Bio (NYSE:NUVB) - Defense World

Feb 27, 2025

Feb 24, 2025

Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference - BioSpace

Feb 24, 2025

Feb 20, 2025

Nuvation Bio Inc. (NYSE:NUVB) Short Interest Up 14.3% in January - MarketBeat

Feb 20, 2025

Feb 19, 2025

Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm - The Eastern Progress Online

Feb 19, 2025

Feb 18, 2025

What Do Wall Street Analysts Think About Nuvation Bio Inc (NYSE: NUVB) Stock? - Stocks Register

Feb 18, 2025

Peapod Lane Capital LLC Makes New $1.04 Million Investment in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Feb 18, 2025

Feb 17, 2025

Nuvation Bio executive departs after key milestones By Investing.com - Investing.com Nigeria

Feb 17, 2025

Feb 14, 2025

Nuvation Bio executive departs after key milestones - MSN

Feb 14, 2025

Feb 13, 2025

Nuvation BioPending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst (NUVB) - Seeking Alpha

Feb 13, 2025

Feb 12, 2025

The Significance of Moving Averages in Nuvation Bio Inc Inc. (NUVB) Price Performance - The InvestChronicle

Feb 07, 2025